当前位置:首页 - 行情中心 - 欧康医药(920230) - 财务分析 - 现金流量表

欧康医药

(920230)

  

流通市值:4.73亿  总市值:10.07亿
流通股本:4724.78万   总股本:1.00亿

现金流量表

报告期2026-09-302026-06-302026-03-312025-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金260,788,828.8169,314,010.4892,294,208.24342,454,164.74
  收到的税费返还3,552,125.723,115,039.581,434,782.527,289,050.71
  收到其他与经营活动有关的现金1,559,365.71,802,9201,188,329.584,766,582.28
  经营活动现金流入小计265,900,320.22174,231,970.0694,917,320.34354,509,797.73
  购买商品、接受劳务支付的现金215,097,352.31134,356,003.5257,185,313.94299,155,453.38
  支付给职工以及为职工支付的现金17,402,420.0413,638,285.797,859,130.0822,986,026.28
  支付的各项税费2,894,745.972,597,626.491,035,435.254,822,420
  支付其他与经营活动有关的现金7,897,854.362,263,491.051,357,482.7320,547,010.77
  经营活动现金流出小计243,292,372.68152,855,406.8567,437,362347,510,910.43
  经营活动产生的现金流量净额22,607,947.5421,376,563.2127,479,958.346,998,887.3
二、投资活动产生的现金流量:
  收回投资收到的现金226,020,713.28152,999,398.6211,183,657186,734,488.82
  取得投资收益收到的现金104,141.4793,592.358,303.85944,990.9
  处置固定资产、无形资产和其他长期资产收回的现金净额50,909.2750,112.8117,851.08130,567
  投资活动现金流入小计226,175,764.02153,143,103.7811,209,811.93187,810,046.72
  购建固定资产、无形资产和其他长期资产支付的现金6,429,265.846,401,051.845,769,708.0627,370,170
  投资支付的现金222,640,000137,760,00030,190,000177,806,915
  投资活动现金流出小计229,069,265.84144,161,051.8435,959,708.06205,177,085
  投资活动产生的现金流量净额-2,893,501.828,982,051.94-24,749,896.13-17,367,038.28
三、筹资活动产生的现金流量:
  吸收投资收到的现金---1,101,600
  取得借款收到的现金20,000,00015,000,0001,000,00021,000,000
  收到其他与筹资活动有关的现金---102,986.8
  筹资活动现金流入小计20,000,00015,000,0001,000,00022,204,586.8
  偿还债务支付的现金21,036,761.1116,036,761.11-20,000,000
  分配股利、利润或偿付利息支付的现金15,501,121.3215,345,801.39143,472.228,352,460.54
  支付其他与筹资活动有关的现金1,247,3291,177,742.12-549,135.46
  筹资活动现金流出小计37,785,211.4332,560,304.62143,472.2228,901,596
  筹资活动产生的现金流量净额-17,785,211.43-17,560,304.62856,527.78-6,697,009.2
四、汇率变动对现金及现金等价物的影响-243,864.99-200,042.48-269,724.71-115,822.79
五、现金及现金等价物净增加额1,685,369.312,598,268.053,316,865.28-17,180,982.97
  加:期初现金及现金等价物余额5,630,407.735,630,407.735,630,407.7322,811,390.7
  期末现金及现金等价物余额7,315,777.0318,228,675.788,947,273.015,630,407.73
补充资料:
  净利润-5,498,112.52-11,435,251.17
  资产减值准备-29,039.8-3,791,435.11
  固定资产和投资性房地产折旧-11,186,939.69-20,430,537.62
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-11,186,939.69-20,430,537.62
  无形资产摊销-351,307.56-639,557
  处置固定资产、无形资产和其他长期资产的损失-21,588.97-975,561.19
  公允价值变动损失--8,741.87--32,327.74
  财务费用-305,301.51-776,951.73
  投资损失--373,858.28--526,165.91
  递延所得税-3,064.48-78,684.84
  其中:递延所得税资产减少-16,692.71-78,684.84
    递延所得税负债增加--13,628.23--
  存货的减少--7,215,585.57--10,226,179.99
  经营性应收项目的减少-15,840,359.43--23,369,924.78
  经营性应付项目的增加--5,681,645.49--3,365,765.85
  其他-1,898,602.01-5,349,153.08
  不涉及现金收支的投资和筹资活动金额其他项目-186,742.76-390,402.54
  现金的期末余额-18,228,675.78-5,630,407.73
  减:现金的期初余额-5,630,407.73-22,811,390.7
  现金及现金等价物的净增加额-12,598,268.05--17,180,982.97
公告日期2026-10-272026-08-272026-04-292026-04-15
审计意见(境内)标准无保留意见
TOP↑